Elamipretide vs Noopept
Head-to-head comparison of Elamipretide (Elamipretide (MTP-131, SS-31)) and Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Elamipretide | Noopept |
|---|---|---|
| Category | Muscle & Performance | Cognitive Enhancement |
| Full Name | Elamipretide (MTP-131, SS-31) | N-phenylacetyl-L-prolylglycine ethyl ester |
| Molecular Weight | 639.8 Da | 318.37 Da |
| Half-Life | 1-4 hours | 20-30 minutes |
| Amino Acids | 4 | N/A |
| Typical Dose | 0.01-0.25 mg/kg/day | 10-30 mg/day |
| Route | Subcutaneous/Intravenous | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 60 |
| Research Status | Clinical | Clinical |
Elamipretide Benefits
- ✓mitochondrial protection
- ✓reduced oxidative stress
- ✓improved fatigue resistance
- ✓may support exercise tolerance
Noopept Benefits
- ✓memory recall
- ✓learning efficiency
- ✓attention support
- ✓neurotrophic signaling
Elamipretide Dosing
0.01-0.25 mg/kg/day SC (clinical research)|daily dosing in trials|alternative IV protocols in some studies
Noopept Dosing
oral research use|10-30 mg per day in human studies|divided or single daily dosing
Elamipretide Side Effects
- ⚠nausea
- ⚠injection-site reactions
- ⚠diarrhea
- ⚠headache
Noopept Side Effects
- ⚠headache
- ⚠irritability
- ⚠sleep disturbance
Research Overview
Elamipretide
Clinical and translational studies show elamipretide can improve mitochondrial function and some functional endpoints in mitochondrial disorders. Skeletal muscle research suggests benefits are driven by energy metabolism rather than direct muscle-building effects.
Noopept
Noopept has been reported to increase NGF/BDNF-related signaling and improve performance in tasks involving learning and recall. Evidence includes preclinical studies and small human studies, but the overall literature is still modest compared with mainstream cognitive drugs.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.